Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-10-31
Target enrollment:
Participant gender:
Summary
The goal of this open label clinical trial is to reduce the effects of restless leg syndrome. The main it questions it aims to answer are:
1. Reduce or eliminate the symptoms of restless leg syndrome.
2. Improve the quality of life of participants with restless leg syndrome.
Participants will be asked to apply the topical cream to the affected area 30 to 45 minutes before bedtime for 14 consecutive days.